Abstract
Pseudomonas aeruginosa has been identified as an important
causative agent of airway infection, mainly in cystic fibrosis.
This disease is characterized by defective mucociliary clearance
induced in part by mucus hyper-production. Mucin is
a major component of airway mucus and is heavily O-glycosylated,
with a protein backbone. Airway infection is known
to be established with bacterial adhesion to mucin. However,
the genes involved in mucin degradation or utilization remain
elusive. In this study, we sought to provide a genetic basis of
P. aeruginosa airway growth by identifying those genes. First,
using RNASeq analyses, we compared genome-wide expression
profiles of PAO1, a prototype P. aeruginosa laboratory
strain, grown in M9-mucin (M9M) and M9-glucose (M9G)
media. Additionally, a PAO1 transposon (Tn) insertion mutants
library was screened for mutants defective in growth
in M9M medium. One mutant with a Tn insertion in the
xcpU gene (PA3100) was determined to exhibit faulty growth
in M9M medium. This gene contributes to the type II secretion
system, suggesting that P. aeruginosa uses this secretion
system to produce a number of proteins to break down and
assimilate the mucin molecule. Furthermore, we screened
the PAO1 genome for genes with protease activity. Of 13 mutants,
one with mutation in PA3247 gene exhibited defective
growth in M9M, suggesting that the PA3247-encoded protease
plays a role in mucin utilization. Further mechanistic
dissection of this particular process will reveal new drug targets,
the inhibition of which could control recalcitrant P. aeruginosa
infections.
Citations
Citations to this article as recorded by

-
Citrobacter rodentium
possesses a functional type II secretion system necessary for successful host infection
Z Krekhno, SE Woodward, A Serapio-Palacios, J Peña-Díaz, KM Moon, LJ Foster, BB Finlay
Gut Microbes.2024;[Epub] CrossRef - Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression
Juliana K. Choi, Samer A. Naffouje, Masahide Goto, Jing Wang, Konstantin Christov, David J. Rademacher, Albert Green, Arlene A. Stecenko, Ananda M. Chakrabarty, Tapas K. Das Gupta, Tohru Yamada
Communications Biology.2023;[Epub] CrossRef - Pseudomonas aeruginosa type IV pili actively induce mucus contraction to form biofilms in tissue-engineered human airways
Tamara Rossy, Tania Distler, Lucas A. Meirelles, Joern Pezoldt, Jaemin Kim, Lorenzo Talà, Nikolaos Bouklas, Bart Deplancke, Alexandre Persat, Victor Sourjik
PLOS Biology.2023; 21(8): e3002209. CrossRef - Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders
Charlotte A. Alemao, Kurtis F. Budden, Henry M. Gomez, Saima F. Rehman, Jacqueline E. Marshall, Shakti D. Shukla, Chantal Donovan, Samuel C. Forster, Ian A. Yang, Simon Keely, Elizabeth R. Mann, Emad M. El Omar, Gabrielle T. Belz, Philip M. Hansbro
Allergy.2021; 76(3): 714. CrossRef - The Bactericidal Tandem Drug, AB569: How to Eradicate Antibiotic-Resistant Biofilm Pseudomonas aeruginosa in Multiple Disease Settings Including Cystic Fibrosis, Burns/Wounds and Urinary Tract Infections
Daniel J. Hassett, Rhett A. Kovall, Michael J. Schurr, Nalinikanth Kotagiri, Harshita Kumari, Latha Satish
Frontiers in Microbiology.2021;[Epub] CrossRef - Structural and functional analysis of the carotenoid biosynthesis genes of aPseudomonasstrain isolated from the excrement of Autumn Darter
Yuki Fukaya, Miho Takemura, Takashi Koyanagi, Takashi Maoka, Kazutoshi Shindo, Norihiko Misawa
Bioscience, Biotechnology, and Biochemistry.2018; 82(6): 1043. CrossRef - Evolutionary conservation of the antimicrobial function of mucus: a first defence against infection
Cassie R Bakshani, Ana L Morales-Garcia, Mike Althaus, Matthew D Wilcox, Jeffrey P Pearson, John C Bythell, J Grant Burgess
npj Biofilms and Microbiomes.2018;[Epub] CrossRef - Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond
Nicholas P. Cianciotto, Richard C. White, Anthony T. Maurelli
Infection and Immunity.2017;[Epub] CrossRef